Cedars-Sinai researchers have received a $10.5 million grant from the California Institute for Regenerative Medicine to launch a clinical trial evaluating stem cell technology for the treatment of retinitis pigmentosa, according to a press release.
The trial includes injecting CNS10-NPC, a cortical progenitor cell product, into one eye of up to 16 patients with retinitis pigmentosa. Vision in both eyes of each patient will be compared and overall safety evaluated.
"We want to make sure the injections do not have unwanted side effects, such as surgical complications or an immune (Read more...)
Uncategorized